American Journal of Health-System Pharmacy, Vol. 64, Issue 4,
385-395
Copyright © 2007 by American Society of Health-System Pharmacists
Implementing an intravenous insulin infusion protocol in the intensive care unit
Rhonda S. Rea,
Amy Calabrese Donihi,
MaryBeth Bobeck,
Peter Herout,
Teresa P. McKaveney,
Sandra L. Kane-Gill and
Mary T. Korytkowski
RHONDA S. REA, PHARM.D., is Assistant Professor, Pharmacy and Therapeutics, Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh (UP), and Critical Care Specialist, Medical Intensive Care Unit, UP Medical Center, Pittsburgh, PA. AMY CALABRESE DONIHI, PHARM.D., is Assistant Professor, Pharmacy and Therapeutics, Department of Pharmacy and Therapeutics, UP. MARYBETH BOBECK, PHARM.D., is Cardiovascular Clinical Pharmacist, Department of Cardiac Services, New Hanover Regional Medical Center, Wilmington, NC. PETER HEROUT, PHARM.D., is Clinical Coordinator, Medical Intensive Care Unit, Advocate Christ Medical Center, Oak Lawn, IL. TERESA P. MCKAVENEY, B.S., is Research Assistant, Department of Pharmacy and Therapeutics, UP. SANDRA L. KANE-GILL, PHARM.D., M.SC., is Assistant Professor, Center for Pharmacoinformatics and Outcomes Research, UP. MARY T. KORYTKOWSKI, M.D., is Professor of Medicine, Division of Endocrinology, Department of Medicine, and Medical Director, Center for Diabetes and Endocrinology, UP, and Chair, UP Medical Center Diabetes Patient Safety Committee.
Address correspondence to Dr. Rea at the Department of Pharmacy and Therapeutics, 200 Lothrop Street, 302 Scaife Hall, Pittsburgh, PA 15213 (rears{at}msx.upmc.edu).
|
Purpose. The implementation of three different insulin protocols in intensive care unit (ICU) settings in two community hospitals and one academic hospital is described.
Summary. Each institution possessed a commitment to improve the existing insulin protocols in order to achieve tighter glycemic control for ICU patients. Studies have shown that the maintenance of tight glycemic control provides improved patient outcomes. Obstacles to implementation of the insulin protocols at the institutions were increased staff workload, difficulties in interpreting algorithms, and lack of perceived benefit. In comparing details of the insulin protocols at the academic and community hospitals, it was found that differences were influenced by the type of institution. The differences among the institutions in the implementation of the protocols included the initial physician response to the protocol, the details of each protocol, nursing staff autonomy, and the involvement of the nursing staff in early protocol development. All three institutions had a dedicated pharmacist in the ICU who committed time toward insulin protocol implementation. For an increased likelihood of successful insulin protocol implementation, a full-time dedicated ICU pharmacist should be assigned to participate on multidisciplinary rounds, provide nursing support and education, and collect process measures to monitor and improve the protocol.
Conclusion. The i.v. insulin infusion protocols developed and implemented in the ICUs at three institutions successfully achieved acceptance and compliance by physicians and nurses. The factors attributed to the success were multidisciplinary involvement, the continuous education of nursing staff, the vigilant involvement of a pharmacist, and flexibility in revising the protocol.
Index terms: Hospitals; Injections; Insulin; Insulins; Pharmacists, hospital; Physicians; Protocols; Workload
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Keene, S. Hailpern, S. Anees, J. Sandhu, M. Harris, L. Ashton, and E. Bellin
Glycemic Control in Critically Ill Patients Before and After Institution of an Intensive Insulin Infusion Protocol: Circadian Rhythm and the Quality Duration Calculator
J Intensive Care Med,
January 1, 2010;
25(1):
31 - 38.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
American Diabetes Association
Standards of Medical Care in Diabetes--2010
Diabetes Care,
January 1, 2010;
33(Supplement_1):
S11 - S61.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M Cyrus, P. M Szumita, B. C Greenwood, and M. L Pendergrass
Evaluation of Compliance with a Paper-based, Multiplication-factor, Intravenous Insulin Protocol
Ann. Pharmacother.,
September 1, 2009;
43(9):
1413 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Moghissi, M. T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I. B. Hirsch, S. E. Inzucchi, F. Ismail-Beigi, M. S. Kirkman, and G. E. Umpierrez
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Diabetes Care,
June 1, 2009;
32(6):
1119 - 1131.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L Erstad
A Primer on Critical Care Pharmacy Services
Ann. Pharmacother.,
December 1, 2008;
42(12):
1871 - 1881.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society of Health-System Pharmacists.
|
|